hamtaro
#164
Excellent video. One of the most informative ever, and a very strong case for 17a-estradiol. Already taking a PDE5 inhibitor, and keeping my eye on the SGL2 inhibitors.
New paper:
The effects of 17α-estradiol treatment on endocrine system revealed by single-nucleus transcriptomic sequencing of hypothalamus
In this study, we investigated the role of 17α-estradiol in lifespan extension and its potential side effects for long-term administration. Pooled hypothalami from aged male Norway brown rats treated with 17α-estradiol (O.T), aged male controls (O), and young male controls (Y) were subjected to single-nucleus transcriptomic sequencing (snRNA-seq). To evaluate the effects of 17α-estradiol in anti-aging in neurons, supervised clustering on neurons by neuropeptides and their receptors were used to evaluate the responses of each neuron subtype during aging and after 17α-estradiol treatment. The elevated cellular metabolism, stresses and decreased synaptic activity in neurons initiated by aging were remarkably attenuated by 17α-estradiol. Assessment of changes in neuron populations showed that neurons related to food intake, reproduction, blood pressure, stress response and electrolyte balance were sensitive to 17α-estradiol treatment. 17α-estradiol treatment not only increased Oxytocin (Oxt), but also increased the activity of hypothalamic-pituitary-gonadal (HPG) axis, evidenced by significantly elevated levels of plasma Gnrh, bioavailable testosterone, and decreased estradiol. Elevated Gnrh1 was verified to be one of the causal effects mediating the role of 17α-estradiol in energy homeostasis, neural synapse, and stress response. Notably, Crh neurons displayed most prominently senescent phenotype among all checked neuron subtypes in O.T, which may be a potential side effect of 17α-estradiol treatment. Therefore, HPG axis and energy metabolism may be key targets of 17α-estradiol in male lifespan extension. Additionally, supervised clustering of neurons was shown to be a useful method to assess the responses to treatment among different neuron subtypes in the hypothalamus.
https://www.biorxiv.org/content/10.1101/2024.06.14.599053v1#:~:text=17α-estradiol%20treatment%20not%20only,bioavailable%20testosterone%2C%20and%20decreased%20estradiol.
PDF:
6 Likes
Bicep
#166
I bought a small amount of pomegranate seed oil and started taking maybe 1cc per day. Maybe 4 days in a row. My skin has never been so smooth. I really didn’t expect anything to happen and have several questions since I have no knowledge on this subject at all.
How much do I absorb through the gut? I expected it to be digested and not survive the stomach. Since I’m taking estrogen with the 17 alpha, is that good too as long as the side effects aren’t annoying? My last checkup my estriol was 17 I think, which is low but not too low.
I welcome any input, thanks.
1 Like
I can find no studies that taking pomegranate seed oil raises estradiol in men.
In one study it reduced menopausal symptoms in women without raising serum estradiol levels. In another study it only mildly increased levels in women.
Several studies say that it increases collagen production and improves skin.
I don’t know for sure, but I don’t think it is going to significantly raise estradiol serum levels in men.
As for cognitive benefits: A study ([4]) investigated a nasal delivery system for pomegranate seed oil and found that nasal administration in a phospholipid oily gel formulation significantly improved memory and locomotor activity in animal models compared to oral administration, suggesting that nasal delivery may enhance the potential cognitive benefits of pomegranate seed oil."
4 Likes
Characterization of craniofacial tissue aging in genetically diverse HET3 male mice with longevity treatment of 17-alpha estradiol
Conclusions:
The HET3 mice present an excellent model with which to study the heterogeneous nature of tooth aging and the effects of longevity interventions. We provide novel data on how 17αE2 improves healthspan by modifying age-related changes in the molar dentin and cementum of male mice.
Open Access Paper:
https://www.sciencedirect.com/science/article/pii/S0003996924002917
2 Likes
I have an estradiol Rx for “gender dysphoria” (as 17-alpha-estradiol is hard to get), should I be worried about 17beta-E2’s DNA binding activity?
jnorm
#170
Sadly we don’t know the doses Longevica used in their patent. I doubt it’s a concern with Rx doses though, and the UK Biobank associations support this.
Out of the 406 drugs studied, 169 had a significant effect on lifespan, after multiple comparison correction (FDR < 0.05). From these 169, as expected, the majority (N = 155, 92%) were associated with increased mortality (Figure 1, Data Table 2 ). These included notably opioids like Morphine sulfate (HR 5.56, CI 4.51-6.86) and Oramorph (HR 5.38, CI 4.08-7.09), the diuretic Furosemide (HR 2.00, CI 1.86-2.15), pain medication Paracetamol (HR 1.48, CI 1.42-1.55) or chronic obstructive pulmonary disease treatment Tiotropium (HR 1.96, CI 1.77-2.17). Importantly, we identified 14 drugs that increased lifespan, compared to health matched controls, independently of current smoking, cancer diagnosis, diabetes, gender, and age at recruitment. These included notably the statin Atorvastatin (HR 0.91, CI 0.87-0.95), the PDE5 inhibitor Sildenafil (HR 0.85, CI 0.78-0.93), the anti-inflammatory drug Naproxen (HR 0.90, CI 0.85-0.96), and the estrogen related drugs Estraderm (HR 0.67, CI 0.51-0.88), Vagifem (HR 0.73, CI 0.59-0.91), Estriol (HR 0.74, CI 0.60-0.92) and Estradiol (HR 0.75, CI 0.59-0.95). Others included, Lymecycline, Otomize, Marvelon, and 2 vaccines (Avaxim, Revaxis).
2 Likes
A new PHD dissertation on this topic:
Evaluating Mechanisms by Which 17α-Estradiol Elicits Health Benefits Across Species
2 Likes
